EBS · —
Basilea Pharmaceutica AG (BSLN.SW) Stock
$52.60
+2.33%
EBS: BSLN.SW
—
—
Valuation
Financials & Margins
Latest News
Jordan Davis to Headline Red Bull Jukebox Texas, Bringing Fan-Powered Country Music Experience to Dallas on August 20
PR Newswire · Aug 12, 2026
Sarah Trott Reintroduces Herself Beyond Reality TV with "From Here to Where"
PR Newswire · Aug 12, 2026
Sector Update: Consumer Stocks Mixed Late Afternoon
MT Newswires · Aug 12, 2026
Sector Update: Tech Stocks Gain Late Afternoon
MT Newswires · Aug 12, 2026
What To Expect From STAAR Surgical’s (STAA) Q2 Earnings
StockStory · Aug 12, 2026
Valuation & Return Ratios
Peer Comparison
About Basilea Pharmaceutica AG
—
Basilea Pharmaceutica AG is led by CEO David Veitch, employs 189 people, headquartered in Allschwil, CH, publicly traded since 2004.
over the past 52 weeks the stock has ranged between $44.70 and $59.20, and currently trades 11.1% below its 52-week high.
Official website: www.basilea.com